These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36359323)

  • 41. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics.
    Palstrøm NB; Overgaard M; Licht P; Beck HC
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
    Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
    Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.
    Creaney J; Segal A; Olsen N; Dick IM; Musk AW; Skates SJ; Robinson BW
    Dis Markers; 2014; 2014():413946. PubMed ID: 25505814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
    Scherpereel A; Grigoriu B; Conti M; Gey T; Grégoire M; Copin MC; Devos P; Chahine B; Porte H; Lassalle P
    Am J Respir Crit Care Med; 2006 May; 173(10):1155-60. PubMed ID: 16456138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
    Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
    Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
    Ferreiro L; Toubes ME; Valdés L
    Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
    Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H
    Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
    Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
    Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.
    Mundt F; Nilsonne G; Arslan S; Csürös K; Hillerdal G; Yildirim H; Metintas M; Dobra K; Hjerpe A
    PLoS One; 2013; 8(8):e72030. PubMed ID: 23991032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
    Tozzoli R; Basso SM; D'Aurizio F; Metus P; Lumachi F
    Clin Biochem; 2016 Nov; 49(16-17):1227-1231. PubMed ID: 27521620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors.
    Zhang X; Lu Y; Huang K; Pan Q; Jia Y; Cui B; Yin P; Li J; Ju J; Fan X; Tian R
    Front Oncol; 2023; 13():1115485. PubMed ID: 37025603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
    Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
    Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
    Liao ND; Chiang TA; Lee WY
    Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
    Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
    Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies.
    Porcel JM; Esquerda A; Rodriguez-Panadero F; Martínez-Iribarren A; Bielsa S
    J Thorac Oncol; 2011 Jan; 6(1):190-4. PubMed ID: 21079519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating unilateral pleural effusions: the role of cytology.
    Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
    Fontana V; Pistillo MP; Vigani A; Canessa PA; Berisso G; Giannoni U; Ferro P; Franceschini MC; Carosio R; Tonarelli M; Rossi C; Dessanti P; Roncella S
    Anticancer Res; 2019 Sep; 39(9):5219-5223. PubMed ID: 31519636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.